TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2022
Back to search
Official data from USPTO
2G UNIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
07/20/2022
Trademark type
Word
Nice classes
1, 5
Filing date
02/18/2021
Registration date
03/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2022
Last transaction
03/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Leiden, NL
Examiner
CASE, LEIGH CAROLINE
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ProteoNic Biotechnology IP B.V.
Representatives
Julianne Abelman Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biological productsreagents for use in the production of polypeptides and monoclonal antibodies for use in the field of in vitro scientific research; Reagents for non-medical usefor scientific research in the field of recombinant DNA technology; Chemicalbiochemical and biological products for non-medical usereagents for scientific and medical research usefor use in manufacturing in the field of recombinant DNA technology; Proteins for use in the field of recombinant DNA technologyproteins for use in recombinant DNA technology manufacturing not for medical use
Class 5
Biological products for medical usereagents for medical use with recombinant DNA technology for the purpose of allowing recombinant production of polypeptides and monoclonal antibodies; Reagents for medical use in the field of recombinant DNA technology
Publications
History of USPTO decisions and trademark events.
24 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2022
DOCK
ASSIGNED TO EXAMINER
01/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/21/2021
PUBO
PUBLISHED FOR OPPOSITION
12/21/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/17/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/17/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/17/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/17/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/17/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2021
ALIE
ASSIGNED TO LIE
10/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/29/2021
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
09/27/2021
GPRA
PRIORITY ACTION E-MAILED
09/27/2021
CPRA
PRIORITY ACTION WRITTEN
09/27/2021
DOCK
ASSIGNED TO EXAMINER
09/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/20/2021
NWAP
NEW APPLICATION ENTERED
02/22/2021
Continuous trademark protection
Get notified about every new filing that threatens 2G UNIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.